Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
10/05/2025
Coinbase stock price increased by 2%.
Latest
9 m ago
"Off-exchange options + spot services" bidirectional empowerment innovative model to solve the operational difficulties of physical enterprises.
10 m ago
Two radar malfunctions in half a month prompt U.S. officials to consider reducing the number of flights at Newark Airport.
12 m ago
Nanhua Futures' Sprint Behind "H Shares": Can International Business Reshape Industry Competition Pattern?
12 m ago
The commercialization process is accelerating, and investment opportunities in the exoskeleton robot industry chain are becoming more prominent.
15 m ago
UBS maintains its rating on Celldex Therapeutics (CLDX.US) and adjusts its rating from Buy to Buy, with a target price adjusted from $44.00 to $38.00.
See all latest